Ovoca Bio PLC
LSE:OVB

Watchlist Manager
Ovoca Bio PLC Logo
Ovoca Bio PLC
LSE:OVB
Watchlist
Price: 1.7 GBX Market Closed
Market Cap: 1.4m GBX
Have any thoughts about
Ovoca Bio PLC?
Write Note

Ovoca Bio PLC
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ovoca Bio PLC
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Ovoca Bio PLC
LSE:OVB
Cash from Financing Activities
-€865k
CAGR 3-Years
40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Perrigo Company PLC
NYSE:PRGO
Cash from Financing Activities
$498.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-7%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Cash from Financing Activities
-$71.6m
CAGR 3-Years
N/A
CAGR 5-Years
36%
CAGR 10-Years
N/A
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Cash from Financing Activities
-$6m
CAGR 3-Years
N/A
CAGR 5-Years
-150%
CAGR 10-Years
N/A
G
GH Research PLC
NASDAQ:GHRS
Cash from Financing Activities
-$204k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Cash from Financing Activities
-€188.6m
CAGR 3-Years
-103%
CAGR 5-Years
N/A
CAGR 10-Years
-14%
No Stocks Found

Ovoca Bio PLC
Glance View

Market Cap
1.5m GBX
Industry
Pharmaceuticals

Ovoca Bio Plc is a clinical-stage biopharmaceutical company. The company is headquartered in Dublin, Dublin and currently employs 5 full-time employees. The firm is engaged in identifying and developing therapeutics targeting the treatment of female sexual dysfunction. The Company’s product BP101 is a synthetic peptide, administered through a nasal spray that is being developed for the treatment of female sexual dysfunction-hypoactive sexual desire disorder (HSDD). The Company’s subsidiaries include Silver Star Ltd, Bulun LLC, Magsel LLC, IVIX LLC and OVB (Australia) Pty Ltd. The firm operates in Ireland, the United Kingdom (UK) and Russia.

OVB Intrinsic Value
2.98 GBX
Undervaluation 43%
Intrinsic Value
Price

See Also

What is Ovoca Bio PLC's Cash from Financing Activities?
Cash from Financing Activities
-865k EUR

Based on the financial report for Jun 30, 2024, Ovoca Bio PLC's Cash from Financing Activities amounts to -865k EUR.

What is Ovoca Bio PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
40%

The average annual Cash from Financing Activities growth rates for Ovoca Bio PLC have been 40% over the past three years .

Back to Top